These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28221685)

  • 41. Old wine in new bottles: strategic alliances within the NCI.
    Ford L
    Front Health Serv Manage; 1991; 7(3):29-31. PubMed ID: 10109086
    [No Abstract]   [Full Text] [Related]  

  • 42. Isolation and culture of melanoma and naevus cells and cell lines.
    Soo JK; Ross AD; Bennett DC
    Methods Mol Biol; 2011; 731():141-50. PubMed ID: 21516405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Newsmaker interview: Harold Varmus. Piloting cancer research with a shrinking budget. Interview by Jocelyn Kaiser.
    Varmus H
    Science; 2011 Jul; 333(6041):397. PubMed ID: 21778374
    [No Abstract]   [Full Text] [Related]  

  • 44. United States military contributions to the National Cancer Institute.
    Sarvis JA; Thompson IM
    Urol Oncol; 2009; 27(5):558-61. PubMed ID: 19720303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Senthil Muthuswamy: a new road map for cancer. Interview by Caitlin Sedwick.
    Muthuswamy S
    J Cell Biol; 2009 Oct; 187(2):152-3. PubMed ID: 19841132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studying cancer in 3 dimensions: 3-D models foster new insights into tumorigenesis.
    Friedrich MJ
    JAMA; 2003 Oct; 290(15):1977-9. PubMed ID: 14559935
    [No Abstract]   [Full Text] [Related]  

  • 47. Interview with director John E. Niederhuber, M.D.: National Cancer Institute stakes out new directions with stimulus funds.
    Niederhuber JE
    J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19736666
    [No Abstract]   [Full Text] [Related]  

  • 48. NCCAM-industry colloquium: exploring opportunities for collaboration.
    Engel LW; Weinberg MS; Coates PM;
    J Altern Complement Med; 2001 Oct; 7(5):579-82. PubMed ID: 11719950
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessing the need for a standardized cancer HUman Biobank (caHUB): findings from a national survey with cancer researchers.
    Massett HA; Atkinson NL; Weber D; Myles R; Ryan C; Grady M; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):8-15. PubMed ID: 21672890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maryland's Special Populations Network. A model for cancer disparities research, education, and training.
    Baquet CR; Mack KM; Mishra SI; Bramble J; Deshields M; Datcher D; Savoy M; Brooks SE; Boykin-Brown S; Hummel K
    Cancer; 2006 Oct; 107(8 Suppl):2061-70. PubMed ID: 16944470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding power relationships in health care networks.
    Addicott R; Ferlie E
    J Health Organ Manag; 2007; 21(4-5):393-405. PubMed ID: 17933371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour Takedown.
    Nurs Stand; 2016 Jul; 30(47):32. PubMed ID: 27440357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and authentication of cancer cell lines: an overview.
    Langdon SP
    Methods Mol Med; 2004; 88():33-42. PubMed ID: 14634216
    [No Abstract]   [Full Text] [Related]  

  • 54. Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.
    Vydelingum NA; Sorbara L; Wagner P; Srivastava S
    Expert Rev Mol Diagn; 2013 Jun; 13(5):421-3. PubMed ID: 23782249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enrichment of cancer stem cell-like cells by culture in alginate gel beads.
    Xu XX; Liu C; Liu Y; Yang L; Li N; Guo X; Sun GW; Ma XJ
    J Biotechnol; 2014 May; 177():1-12. PubMed ID: 24607645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A national cancer clinical trials system for targeted therapies.
    Mendelsohn J
    Sci Transl Med; 2011 Mar; 3(75):75cm8. PubMed ID: 21430266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and culture of leukemia-lymphoma cell lines.
    Drexler HG
    Methods Mol Biol; 2011; 731():181-200. PubMed ID: 21516408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NCI-MATCH pairs tumor mutations with matching drugs.
    Brower V
    Nat Biotechnol; 2015 Aug; 33(8):790-1. PubMed ID: 26252121
    [No Abstract]   [Full Text] [Related]  

  • 59. Essential techniques of cancer cell culture.
    MacLeod KG; Langdon SP
    Methods Mol Med; 2004; 88():17-29. PubMed ID: 14634215
    [No Abstract]   [Full Text] [Related]  

  • 60. Group Aims to Make 1,000 Cancer Cell Lines.
    Cancer Discov; 2016 Oct; 6(10):1074. PubMed ID: 27543583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.